Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Toxicology in Vitro

• Publication date

  2007-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.TIV.2007.09.007PMID 16930941
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design‐based stereological estimation of hepatocyte number, by combining the smooth optical fractionator and immunocytochemistry with anti‐carcinoembryonic antigen polyclonal antibodies

  2006cited by this paper
• Determination of the hepatocellularity number for human, dog, rabbit, rat and mouse livers from protein concentration measurements

  2006cited by this paper
• Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver.

  2003cited by this paper
• Utility of hepatocytes to model species differences in the metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and man.

  1999cited by this paper
• Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.

  1999cited by this paper
• Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam.

  1997cited by this paper
• Kinetics of drug metabolism in rat liver slices. II. Comparison of clearance by liver slices and freshly isolated hepatocytes.

  1996cited by this paper
• Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.

  1995cited by this paper
• Relevance of in vitro kinetic parameters to in vivo metabolism of xenobiotics.

  1994cited by this paper
• Prediction of intrinsic clearance of loxtidine from kinetic studies in rat, dog and human hepatocytes.

  1990cited by this paper
• PHENOTYPIC STABILITY OF ADULT RAT HEPATOCYTES IN PRIMARY MONOLAYER CULTURE *

  1980cited by this paper
• The isolation of hormone-sensitive rat hepatocytes by a modified enzymatic technique.

  1974cited by this paper
• Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion.

  1973cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• A preliminary evaluation of the applicability of the in vitro to in vivo extrapolation approach to quantitative risk assessment.

  2026cites this paper
• Replication-driven HBV cccDNA loss in chimeric mice with humanized livers

  2025cites this paper
• In vitro and In Vivo Drug Metabolism Analysis of BPI-460372 - A Covalent TEAD1/3/4 Inhibitor

  2025cites this paper
• Exploiting the Cryptic αD Pocket of Casein Kinase 2α (CK2α) to Deliver Highly Potent and Selective Type 1 Inhibitors

  2025cites this paper
• Metabolic Stability and Comprehensive Metabolite Profiling of Chrysotobibenzyl in Human Liver Microsomes and Hepatocytes Employing UPLC-MS/MS and UPLC-Orbitrap-HRMS Analysis.

  2025cites this paper
• Spatiotemporal liver dynamics shape hepatocellular heterogeneity and impact in vivo gene engineering

  2025cites this paper
• Optimized Protocol for Primary Rat Hepatocyte Isolation and a Model for Investigating Experimental Steatosis

  2025cites this paper
• HBVZ10, an AAV8 vector-based new HBV therapy candidate for cccDNA elimination

  2025cites this paper
• DNA replication in primary hepatocytes without the six-subunit ORC

  2025cites this paper
• Targeting Melanin Production: The Safety of Tyrosinase Inhibition

  2025cites this paper
• Quantitative prediction of drug disposition for uridine diphosphate-glucuronosyltransferase substrates using humanized mice.

  2025cites this paper
• Somatic mutations impose an entropic upper bound on human lifespan

  2025cites this paper
• Radiopharmaceutical kit to prepare Copper-64 labelled porphyrin-lipid nanoparticles for radiotracer imaging studies in cancer patients

  2025cites this paper
• Comprehensive identification and characterization of in vitro and in vivo metabolites of the novel GLP-1 receptor agonist danuglipron using UHPLC-QToF-MS/MS.

  2025cites this paper
• The deLIVERed promises of gene therapy: past, present and future of liver-directed gene therapy.

  2025cites this paper
• Quantitative prediction of CYP2C9-mediated drug disposition using humanized mice.

  2025cites this paper
• Guidelines for Manufacturing and Application of Organoids: Liver

  2024cites this paper
• PK/PD investigation of antiviral host matriptase/TMPRSS2 inhibitors in cell models

  2024cites this paper
• Cytometry in the Short-Wave Infrared

  2024cites this paper
• Hepatitis B virus core protein as a Rab-GAP suppressor driving liver disease progression.

  2024cites this paper
• Characterization of preclinical radio ADME properties of ARV-471 for predicting human PK using PBPK modeling

  2024cites this paper
• Editorial: Reading the cholate—A new gateway to portal hypertension and oesophageal varices: Authors' reply

  2024cites this paper
• Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes

  2024cites this paper
• DNA replication in primary hepatocytes without the six-subunit ORC

  2024influential citation
• Therapeutic liver cell transplantation to treat murine PKU

  2024cites this paper
• Dose Prediction and Pharmacokinetic Simulation of XZP-5610, a Small Molecule for NASH Therapy, Using Allometric Scaling and Physiologically Based Pharmacokinetic Models

  2024cites this paper
• Relevance of RNA to the therapeutic efficacy of mesenchymal stromal/stem cells extracellular vesicles

  2024cites this paper
• In vivo interaction screening reveals liver-derived constraints to metastasis

  2024cites this paper
• Conquering the beyond Rule of Five Space with an Optimized High-Throughput Caco-2 Assay to Close Gaps in Absorption Prediction

  2024cites this paper
• Prolonged activity of the transposase helper may raise safety concerns during DNA transposon-based gene therapy.

  2023cites this paper
• A transgenic mouse line for assaying tissue-specific changes in endoplasmic reticulum proteostasis

  2023cites this paper
• In vivo screening of tumor-hepatocyte interactions identifies Plexin B2 as a gatekeeper of liver metastasis

  2023cites this paper
• Manufacturing and Functional Characterization of Bioengineered Liver Grafts for Extracorporeal Liver Assistance in Acute Liver Failure

  2023cites this paper
• Clonal population expansion of Staphylococcus aureus occurs due to escape from a finite number of intraphagocyte niches

  2023cites this paper
• Variation in the CENP-A sequence association landscape across diverse inbred mouse strains

  2023cites this paper
• Characterization of the humanized FRG mouse model and development of an AAV-LK03 variant with improved liver lobular biodistribution

  2023cites this paper
• Virally induced CRISPR/Cas9-based knock-in of fluorescent albumin allows long-term visualization of cerebral circulation in infant and adult mice

  2023cites this paper
• Easy-to-Assembly System for Decellularization and Recellularization of Liver Grafts in a Bioreactor

  2023cites this paper
• ROCK inhibition enhanced hepatocyte liver engraftment by retaining membrane CD59 and attenuating complement activation.

  2023cites this paper
• Mechanistic Static Model based Prediction of Transporter Substrate Drug-Drug Interactions Utilizing Atorvastatin and Rifampicin

  2023cites this paper
• In Vitro Pharmacokinetic Behavior of Antiviral 3-Amidinophenylalanine Derivatives in Rat, Dog and Monkey Hepatocytes

  2023cites this paper
• Personalised modelling of clinical heterogeneity between medium-chain acyl-CoA dehydrogenase patients

  2023cites this paper
• Complement-dependent uptake of nanoparticles by blood phagocytes: brief overview and perspective.

  2023cites this paper
• Quantitative prediction of CYP3A‐mediated drug–drug interactions by correctly estimating fraction metabolized using human liver chimeric mice

  2023cites this paper
• Intravenous liposomal vaccine enhances CTL generation, but not until antigen presentation.

  2022cites this paper
• Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated–Hepatitis B Virus–Infected Mice

  2022influential citation
• A Historical Review of Brain Drug Delivery

  2022cites this paper
• Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated – Hepatitis B Virus – Infected Mice S

  2022influential citation
• Comparison of extraction methods for intracellular metabolomics of human tissues

  2022cites this paper
• Hepatic bile acid synthesis and secretion: comparison of in vitro methods.

  2022cites this paper
• Quantitative Comparison of Avian and Mammalian Physiologies for Parameterization of Physiologically Based Kinetic Models

  2022cites this paper
• Strain level centromere variation influences CENP-A association dynamics and centromere function

  2022cites this paper
• Model-Based Assessment of the Contribution of Monocytes and Macrophages to the Pharmacokinetics of Monoclonal Antibodies

  2022cites this paper
• Direct, indirect, post-infection damages induced by coronavirus in the human body: an overview

  2022cites this paper
• Insulin Clearance in Obesity and Type 2 Diabetes

  2022cites this paper
• Comparison of extraction methods for intracellular metabolomics

  2021cites this paper
• Disposition and metabolism of ethylene glycol 2-ethylhexyl ether in Sprague Dawley rats, B6C3F1/N mice, and in vitro in rat hepatocytes

  2021cites this paper
• The Use of Nanomaterial In Vivo Organ Burden Data for In Vitro Dose Setting.

  2021cites this paper
• Kinetic Analysis of Lidocaine Elimination by Pig Liver Cells Cultured in 3D Multi-Compartment Hollow Fiber Membrane Network Perfusion Bioreactors

  2021cites this paper
• Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of N-Acetylgalactosamine–Conjugated Small Interfering RNA Disposition and Gene Silencing in Preclinical Species and Humans

  2021cites this paper
• The intersection of vector biology, gene therapy, and hemophilia

  2021cites this paper
• Conditions for maintenance of hepatocyte differentiation and function in 3D cultures

  2021cites this paper
• Bistability in fatty-acid oxidation resulting from substrate inhibition

  2021cites this paper
• Convergent somatic mutations in metabolism genes in chronic liver disease

  2021cites this paper
• Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data

  2021cites this paper
• Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)

  2021cites this paper
• Successful and Unsuccessful Prediction of Human Hepatic Clearance for Lead Optimization.

  2021cites this paper
• Prediction of human pharmacokinetics for low‐clearance compounds using pharmacokinetic data from chimeric mice with humanized livers

  2021cites this paper
• Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques

  2021cites this paper
• Response by Dichek to Letter Regarding Article, "Jugular Vein Injection of High-Titer Lentiviral Vectors Does Not Transduce the Aorta".

  2021cites this paper
• Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

  2021cites this paper
• A Nanoprimer to improve the systemic delivery of siRNA and mRNA.

  2020cites this paper
• Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure

  2020cites this paper
• Long-Term Survival of Transplanted Autologous Canine Liver Organoids in a COMMD1-Deficient Dog Model of Metabolic Liver Disease

  2020cites this paper
• High Dose Versus Low Dose Syngeneic Hepatocyte Transplantation in Pex1-G844D NMRI Mouse Model is Safe but Does Not Achieve Long Term Engraftment

  2020cites this paper
• Synthesis and evaluation of new 4-peptidamido-2-fluorobenzyl phosphoramide mustard conjugates as prodrugs activated by prostate-specific antigen

  2020cites this paper
• Estimating hepatitis B virus cccDNA persistence in chronic infection

  2020cites this paper
• Reply to: Lactate measurements in an integrated perfusion machine for human livers

  2020cites this paper
• Predicting the Disposition of the Antimalarial Drug Artesunate and Its Active Metabolite Dihydroartemisinin Using Physiologically Based Pharmacokinetic Modeling

  2020cites this paper
• Cell Tracking: Methods and Protocols

  2020cites this paper
• Cell release during perfusion reflects cold ischemic injury in rat livers

  2020cites this paper
• Comparison of the Efficacy and Sensitivity of Alternative PET Reporter Gene/PET Reporter Probe Systems That Minimize Biological Variables.

  2020cites this paper
• Novel testing strategy for prediction of rat biliary excretion of intravenously administered estradiol-17β glucuronide

  2020influential citation
• Metabolic profiling of ligustilide and identification of the metabolite in rat and human hepatocytes by liquid chromatography combined with high resolution mass spectrometry.

  2020cites this paper
• A hybrid model to evaluate the impact of active uptake transport on hepatic distribution of atorvastatin in rats

  2020cites this paper
• An Activation-Clearance Model for Plasmodium vivax Malaria

  2020cites this paper
• In vivo absolute quantification of hepatic γ‐ATP concentration in mice using 31P MRS at 11.7 T

  2020cites this paper
• Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations

  2020cites this paper
• Prediction of Clinical Transporter‐Mediated Drug–Drug Interactions via Comeasurement of Pitavastatin and Eltrombopag in Human Hepatocyte Models

  2020cites this paper
• The Role of Alcohol Consumption on Acetaminophen Induced Liver Injury: Implications from A Mathematical Model

  2020cites this paper
• Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical Pipeline.

  2020cites this paper
• Improved inhibitory and ADMET properties of blebbistatin derivatives indicate that blebbistatin scaffold is ideal for drug development targeting myosin-2

  2020cites this paper
• Interleukin‐6 signaling requires only few IL‐6 molecules: Relation to physiological concentrations of extracellular IL‐6

  2020cites this paper
• Metabolic profiling of senkyunolide A and identification of the metabolite in hepatocytes by ultra-high performance liquid chromatography combined with diode array detector and high resolution mass spectrometry.

  2020cites this paper
• Combination of cord blood‐derived human hepatic progenitors and hepatogenic factors strongly improves recovery after acute liver injury in mice through modulation of the Wnt/β‐catenin signaling

  2019cites this paper
• A Complete Approach to Predict Biodistribution of Nanomaterials Within Animal Species from In-vitro Data

  2019cites this paper
• Mechanistic modelling of in vitro transporter processes to improve drug-drug interaction predictions

  2019influential citation
• Mechanistic Modeling of the Hepatic Disposition of Estradiol-17β-Glucuronide in Sandwich-Cultured Human Hepatocytes

  2019cites this paper
• Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism.

  2019cites this paper
• Testing the ability of in-vitro depletion rates to assess the biotransformation rate and bioconcentration factor of hydrophobic chemicals in rainbow trout (Oncorhynchus mykiss)

  2018cites this paper